A Phase II Clinical Study of BBI503 in Adult Patients With Advanced Gastrointestinal Stromal Tumors
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 05 Apr 2018
At a glance
- Drugs Amcasertib (Primary)
- Indications Gastrointestinal stromal tumours
- Focus Therapeutic Use
- Sponsors Boston Biomedical
- 30 Mar 2018 Status changed from recruiting to active, no longer recruiting.
- 10 Jun 2017 Biomarkers information updated
- 25 Mar 2017 Status changed from not yet recruiting to recruiting.